Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index >= 27 kg/m(2)

DSpace Repository

Show simple item record

dc.contributor.author Birkenfeld, Andreas L.
dc.date.accessioned 2020-12-15T11:57:09Z
dc.date.available 2020-12-15T11:57:09Z
dc.date.issued 2020
dc.identifier.issn 1463-1326
dc.identifier.uri http://hdl.handle.net/10900/110705
dc.language.iso en de_DE
dc.publisher Wiley de_DE
dc.relation.uri http://dx.doi.org/10.1111/dom.14144 de_DE
dc.subject.ddc 610 de_DE
dc.title Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index >= 27 kg/m(2) de_DE
dc.type Artikel de_DE
utue.quellen.id 20200929220116_00205
utue.personen.roh Mathieu, Chantal
utue.personen.roh Dandona, Paresh
utue.personen.roh Birkenfeld, Andreas L.
utue.personen.roh Hansen, Troels Krarup
utue.personen.roh Iqbal, Nayyar
utue.personen.roh Xu, John
utue.personen.roh Repetto, Enrico
utue.personen.roh Scheerer, Markus Florian
utue.personen.roh Thoren, Fredrik
utue.personen.roh Phillip, Moshe
dcterms.isPartOf.ZSTitelID Diabetes Obesity & Metabolism de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record